The tranSMART Foundation to Hold International Developers Meeting for Its Open-Source Translational Medicine Research Platform
Recombinant by Deloitte to Host Event; Sanofi, BT Global, Imperial College of London, and theHyve to Sponsor
February 06, 2014 --
WAKEFIELD, MA -- (Marketwired) -- 02/06/14 -- The tranSMART Foundation, a non-profit organization providing a global, open-source knowledge management platform for scientists to share pre-competitive translational research data, today announced that it is hosting an International Developers Meeting February 5-7, 2014 at Recombinant by Deloitte's location in Newton, Mass.
In addition to Recombinant by Deloitte, Sanofi, BT Global, Imperial College of London, and theHyve will sponsor the three-day event. Developers from these organizations, as well as the University of Michigan, Harvard University, Pfizer, Johnson & Johnson, among others are expected to participate.
"The success of the tranSMART platform relies on our global open-source community of users and developers that are dedicated to developing innovative applications and advancing the platform," said tranSMART Foundation CEO Keith Elliston. "These events are an excellent opportunity for the community to come together, brainstorm ideas and further enhance the platform to drive translational biomedical research projects. We thank our host and sponsors for this meeting. Without the support of the community, the success of this open-source platform would not be possible."
The meeting will include an update on the tranSMART platform, discussions on current projects using the platform and development of a programming roadmap for the release of version 1.2 of the software.
About The tranSMART Foundation
The tranSMART Foundation is a non-profit organization that provides an open-source, cloud-based, data-sharing and analysis platform that enables scientists at universities, disease foundations, pharmaceutical companies, and government agencies around the world to share pre-competitive data in a way that saves money and time in translating research findings into new therapies and diagnostic tools. Founded to steward the tranSMART platform, the Foundation is headquartered in Wakefield, Massachusetts with Centers of Excellence in Ann Arbor, Mich.; London, England; Boston, Mass.; and Amsterdam, Netherlands. The tranSMART Foundation can also be found on the web at www.tranSMARTFoundation.org.
A&E Communications, Inc.
Copyright @ Marketwire